The industry experienced aggressive growth during the past five years, benefiting from an aging US population and an expansion in private health-related research and development. These factors will continue to propel industry revenue in the next five years; however, mounting competition and the prevalence of long-term strategic partnerships between contract research organizations and drug manufacturers will slightly slow growth.
This industry includes companies that provide research services on a contract basis to the pharmaceutical and biotechnology industries. Contract research organizations (CRO) provide biopharmaceutical development, preclinical research, clinical research and clinical trial management. Many CROs specifically provide clinical study and clinical trial support for drugs or medical devices.
This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.